DOJ – Page 6 – Policy & Medicine

DOJ Announces $1.2 Million Settlement with Respironics

Biogen $900 Million Settlement Agreement Finalized

Policy and Medicine Compliance Update October, 2022 Issue Covers HHS Self Disclosure and DOJ Enforcement Policies, Omnicare FCA Case, and Stem Cell Research

DOJ Opens Criminal Probe into Cassava Sciences

DOJ Announces Charges Against 36 For $1.2 Billion in Health Care Fraud

DOJ Reaches Settlement with California Doctor Over False Claims Act Allegations

Biogen Reaches $900 Million Settlement in False Claims Act Case

DOJ Announces $9.85 Million False Claims Act Settlement Over Above-Market Rent Payments

Biotronik Reaches Nearly $13 Million Settlement with DOJ Over Alleged False Claims Act Violations

Policy and Medicine Compliance Update July 2022 Issue: Compliance Operations, Speaker Programs, CCO Settlement Certifications, and DOJ Genetic Testing Settlements